As of Apr 29
| -0.68 / -1.73%|
The 4 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 44.50, with a high estimate of 45.00 and a low estimate of 40.00. The median estimate represents a +15.52% increase from the last price of 38.52.
The current consensus among 5 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.